Shopping Cart 0
Cart Subtotal
USD 0

Melinta Therapeutics Inc-Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 375

Details

Melinta Therapeutics Inc-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-GlobalData's summarization of the company's business strategy.

SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Highlights

Melinta Therapeutics Inc (Melinta) is a biopharmaceutical company that focuses on the development of novel antibiotics. Its drugs are intended to treat the various bacterial infections. The company's lead product Baxdela (delafloxacin) has been approved by the US FDA as an IV treatment for serious skin infections known as acute bacterial skin and skin structure infections (ABSSSI). Delafloxacin is also being as an investigational antibiotic for Serious Community-Acquired Bacterial Pneumonia (CABP) and Complicated Urinary Tract Infections (cUTI). It also has multiple Oxazolidinone and Macrolide Programs in Pre-clinical and Clinical studies. The products are based on its ribosome crystallography platform, engineered to overcome the problem of drug resistance. The company has partnerships with Menarini Group; Malin Plc; Eurofarma Laboratorios for the commercialization of its products. Melinta is headquartered at New Haven, Connecticut, the US.

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Melinta Therapeutics Inc-Key Facts 5

Melinta Therapeutics Inc-Key Employees 6

Melinta Therapeutics Inc-Key Employee Biographies 7

Melinta Therapeutics Inc-Major Products and Services 8

Melinta Therapeutics Inc-History 9

Melinta Therapeutics Inc-Company Statement 10

Melinta Therapeutics Inc-Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2-Company Analysis 12

Melinta Therapeutics Inc-Business Description 12

Melinta Therapeutics Inc-Corporate Strategy 13

Melinta Therapeutics Inc-SWOT Analysis 14

SWOT Analysis-Overview 14

Melinta Therapeutics Inc-Strengths 14

Melinta Therapeutics Inc-Weaknesses 15

Melinta Therapeutics Inc-Opportunities 16

Melinta Therapeutics Inc-Threats 17

Melinta Therapeutics Inc-Key Competitors 18

Section 3-Company's Lifesciences Financial Deals and Alliances 19

Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 19

Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 20

Melinta Therapeutics Inc, Recent Deals Summary 21

Section 4-Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22


List Of Figure

List of Figures

Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 19

Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 20


List Of Table

List of Tables

Melinta Therapeutics Inc, Key Facts 5

Melinta Therapeutics Inc, Key Employees 6

Melinta Therapeutics Inc, Key Employee Biographies 7

Melinta Therapeutics Inc, Major Products and Services 8

Melinta Therapeutics Inc, History 9

Melinta Therapeutics Inc, Other Locations 11

Melinta Therapeutics Inc, Key Competitors 18

Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 19

Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 20

Melinta Therapeutics Inc, Recent Deals Summary 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Melinta Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.

Company Profile

Company Profile Title

Melinta Therapeutics Inc-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-GlobalData's summarization of the company's business strategy.

SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Highlights

Melinta Therapeutics Inc (Melinta) is a biopharmaceutical company that focuses on the development of novel antibiotics. Its drugs are intended to treat the various bacterial infections. The company's lead product Baxdela (delafloxacin) has been approved by the US FDA as an IV treatment for serious skin infections known as acute bacterial skin and skin structure infections (ABSSSI). Delafloxacin is also being as an investigational antibiotic for Serious Community-Acquired Bacterial Pneumonia (CABP) and Complicated Urinary Tract Infections (cUTI). It also has multiple Oxazolidinone and Macrolide Programs in Pre-clinical and Clinical studies. The products are based on its ribosome crystallography platform, engineered to overcome the problem of drug resistance. The company has partnerships with Menarini Group; Malin Plc; Eurofarma Laboratorios for the commercialization of its products. Melinta is headquartered at New Haven, Connecticut, the US.

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Melinta Therapeutics Inc-Key Facts 5

Melinta Therapeutics Inc-Key Employees 6

Melinta Therapeutics Inc-Key Employee Biographies 7

Melinta Therapeutics Inc-Major Products and Services 8

Melinta Therapeutics Inc-History 9

Melinta Therapeutics Inc-Company Statement 10

Melinta Therapeutics Inc-Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2-Company Analysis 12

Melinta Therapeutics Inc-Business Description 12

Melinta Therapeutics Inc-Corporate Strategy 13

Melinta Therapeutics Inc-SWOT Analysis 14

SWOT Analysis-Overview 14

Melinta Therapeutics Inc-Strengths 14

Melinta Therapeutics Inc-Weaknesses 15

Melinta Therapeutics Inc-Opportunities 16

Melinta Therapeutics Inc-Threats 17

Melinta Therapeutics Inc-Key Competitors 18

Section 3-Company's Lifesciences Financial Deals and Alliances 19

Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 19

Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 20

Melinta Therapeutics Inc, Recent Deals Summary 21

Section 4-Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22


List Of Figure

List of Figures

Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 19

Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 20


List Of Table

List of Tables

Melinta Therapeutics Inc, Key Facts 5

Melinta Therapeutics Inc, Key Employees 6

Melinta Therapeutics Inc, Key Employee Biographies 7

Melinta Therapeutics Inc, Major Products and Services 8

Melinta Therapeutics Inc, History 9

Melinta Therapeutics Inc, Other Locations 11

Melinta Therapeutics Inc, Key Competitors 18

Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 19

Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 20

Melinta Therapeutics Inc, Recent Deals Summary 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Melinta Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.